Table 1.
Molecule | Function | Period | Cell Line | Timeline | Reference |
---|---|---|---|---|---|
T3 | Increase MAFA expression | Stage 5 | CyT49 | Five stages (21+ days) | [23] |
ALK5 inhibitor | Increase MAFA expression | Stage 5~7 | H1 | Seven stages (~40 days) | [2] |
Exendin-4 | Improve β-cell maturation | Stage 4 | H9, H1 | Four stages (22 days) | [4] |
Stage 5 | H1, Epi-9, iPS1-10 | Five stages (30 days) | [39] | ||
RA | Increase PDX1, PAX4, and GLUT2 expression | Stage 3 | MEL1/INSGFP/W | Five stages (20 days) | [40] |
Stage 3~5 | HUES8, iPSC-1, iPSC-2 | Five stages (~35 days) | [3] | ||
Tankyrase inhibitor G007-LK | Inhibit Wnt signaling | Stage 7 | ND41866 | Seven stages (~40 days) | [41] |